With $263M, LifeMine unearths a new drug for organ transplants
Led by serial biotech entrepreneur Greg Verdine, the startup mined fungi genomes to find a safer alternative to the drugs widely used to prevent the body from rejecting transplanted organs.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
